4//SEC Filing
Oakes Gregory 4
Accession 0001415889-20-001020
CIK 0001604191other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 9:51 PM ET
Size
6.1 KB
Accession
0001415889-20-001020
Insider Transaction Report
Form 4
Oakes Gregory
Director
Transactions
- Award
Options
2020-04-13+60,000→ 60,000 totalExercise: $0.97Exp: 2030-04-13→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]Options granted in connection with the Reporting Person's appointment as a director to serve on the Board of the Issuer for the remainder of the fiscal year ending December 31, 2020 pursuant to the Issuer's 2014 Omnibus Equity Incentive Plan. The options vest in three equal installments on each of June 30, 2020, September 30, 2020, and December 31, 2020, in accordance with the Issuer's Director Compensation Plan ("Plan"). The Plan provides for the grant to each independent director of options to purchase 80,000 shares of common stock for service on the Board during the fiscal year ending December 31, 2020, which vest ratably each quarter during the fiscal year. The exercise price was determined based on the higher of the last price paid for shares of the Issuer's common stock or the fair market value of Issuer's common stock on the date of grant.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001809796
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 9:51 PM ET
- Size
- 6.1 KB